Teriparatid
Prijeđi na navigaciju
Prijeđi na pretragu
Klinički podaci | |||
---|---|---|---|
Robne marke | Apthela, Forsteo, Forteo, Fortessa | ||
AHFS/Drugs.com | Monografija | ||
Identifikatori | |||
CAS broj | 52232-67-4 | ||
ATC kod | H05AA02 | ||
PubChem[1][2] | 16133850 | ||
DrugBank | DB06285 | ||
Hemijski podaci | |||
Formula | C181H291N55O51S2 | ||
Mol. masa | 4117.72 g/mol | ||
SMILES | eMolekuli & PubHem | ||
| |||
Farmakoinformacioni podaci | |||
Trudnoća | ? | ||
Pravni status | |||
Način primene | Subkutano |
Teriparatid (Forteo, Eli Lilly and Company) je rekombinantna forma paratiroidnog hormona. On je efektivan anabolik (i.e., stimuliše rast kostiju)[3] koji se koristi za lečenje pojedinih formi osteoporoze.[4][5][6][7][8]
Reference[uredi | uredi kod]
- ↑ Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.
- ↑ Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1.
- ↑ Riek AE and Towler DA (2011). „The pharmacological management of osteoporosis”. Missouri Medicine 108 (2): 118–23. PMID 21568234.
- ↑ Saag KG, Shane E, Boonen S, et al. (November 2007). „Teriparatide or alendronate in glucocorticoid-induced osteoporosis”. The New England Journal of Medicine 357 (20): 2028–39. DOI:10.1056/NEJMoa071408. PMID 18003959.
- ↑ Stroup J, Kane MP, Abu-Baker AM: Teriparatide in the treatment of osteoporosis. Am J Health Syst Pharm. 2008 Mar 15;65(6):532-9. PMID 18319498
- ↑ Close P, Neuprez A, Reginster JY: Developments in the pharmacotherapeutic management of osteoporosis. Expert Opin Pharmacother. 2006 Aug;7(12):1603-15. PMID 16872263
- ↑ Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035-41. DOI:10.1093/nar/gkq1126. PMC 3013709. PMID 21059682.
- ↑ David S. Wishart, Craig Knox, An Chi Guo, Dean Cheng, Savita Shrivastava, Dan Tzur, Bijaya Gautam, and Murtaza Hassanali (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Res 36 (Database issue): D901-6. DOI:10.1093/nar/gkm958. PMC 2238889. PMID 18048412.
Literatura[uredi | uredi kod]
- Hardman JG, Limbird LE, Gilman AG. (2001). Goodman & Gilman's The Pharmacological Basis of Therapeutics (10 izd.). New York: McGraw-Hill. DOI:10.1036/0071422803. ISBN 0-07-135469-7.
- Thomas L. Lemke, David A. Williams, ur. (2007). Foye's Principles of Medicinal Chemistry (6 izd.). Baltimore: Lippincott Willams & Wilkins. ISBN 0-7817-6879-9.